# ACAT (NP Life Sciences Health Industry Group Inc.) - SEC EDGAR Financial Statements

> NP Life Sciences Health Industry Group Inc. reported $165K in revenue and a net loss of $2.9K for the fiscal year ended December 31, 2023 (up 61.4% year over year), with a -0.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/ACAT
- Markdown: https://convexityos.com/fundamentals/ACAT.md
- SEC CIK: 0001781726
- Reporting currency: USD
- Latest filing period: December 31, 2023
- Last synced: Nov 20, 2026, 05:37 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001781726&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2023 | $165K | +61.4% YoY |
| Operating Income | FY 2023 | -$690 | -0.4% margin |
| Net Income | FY 2023 | -$2.9K | -1.8% net margin |
| Diluted EPS | FY 2023 | $0.00 | Split-adjusted |
| Free Cash Flow | FY 2023 | -- | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2023 | $71K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $165K | $102K | $35K | $15K | $43K |
| **Operating Income** | -$690 | -$19K | -$66K | -$131K | -$109K |
| Interest Income | -- | -- | $4 | $26 | $32 |
| Interest Expense | $645 | $1 | -- | -- | -- |
| Income Before Tax | -$1.3K | -$19K | -$66K | -$131K | -$109K |
| Income Tax Expense | $1.6K | -- | -- | -- | -- |
| **Net Income** | -$2.9K | -$19K | -$66K | -$131K | -$109K |
| Basic EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 43.0M | 43.0M | 43.0M | 43.0M | 34.1M |
| Diluted Shares Outstanding | 43.0M | 43.0M | 43.0M | 43.0M | 34.1M |

### Income Statement (Quarterly)

| Line Item | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $10K | $18K | $107K | $30K | -- | $41K | $15K | -- |
| **Operating Income** | -$36K | -$37K | $71K | $1.2K | $17K | -$5.4K | $1.1K | -$31K |
| Interest Income | -- | -- | -- | -- | -- | -- | $1 | -- |
| Income Before Tax | -$37K | -$37K | -- | $1.2K | $17K | -$5.4K | $1.1K | -$31K |
| **Net Income** | -$15K | -$38K | $71K | $1.2K | $17K | -$5.4K | $1.1K | -$31K |
| Basic EPS | -- | -- | -- | $0.00 | -- | -- | -- | $0.00 |
| Basic Shares Outstanding | -- | 43.0M | 43.0M | 43.0M | -- | 43.0M | 43.0M | 43.0M |
| Diluted Shares Outstanding | -- | 43.0M | 43.0M | -- | -- | 43.0M | 43.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $71K | $122K | $28K | $119K | $243K | $200 |
| **Cash & Short-Term Investments** | $71K | $122K | $28K | $119K | $243K | $200 |
| **Total Current Assets** | -- | -- | -- | -- | -- | $200 |
| Intangible Assets | -- | -- | -- | -- | $7.2K | -- |
| **Total Non-Current Assets** | -- | -- | -- | -- | -- | $0 |
| **Total Assets** | $77K | $128K | $38K | $119K | $250K | $200 |
| Accounts Payable | $6.1K | $6.1K | -- | -- | $1.0K | $466 |
| Deferred Revenue (Current) | -- | $100K | -- | -- | -- | -- |
| **Total Current Liabilities** | $38K | $108K | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $22K | $0 | -- | -- | -- | -- |
| **Total Liabilities** | $60K | $108K | $239 | $15K | $15K | $21K |
| Common Stock | $4.3K | $4.3K | $4.3K | $4.3K | $4.4K | $7 |
| Retained Earnings | -$348K | -$345K | -$326K | -$261K | -$130K | -$21K |
| **Total Stockholders' Equity** | -- | $19K | $38K | $104K | $235K | -$21K |
| Total Equity | $16K | $19K | $38K | $104K | $235K | -$21K |

### Balance Sheet (Quarterly)

| Line Item | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $71K | $85K | $125K | $140K | $122K | $7.0K | $575 | $23K |
| **Cash & Short-Term Investments** | $71K | $85K | $125K | $140K | $122K | $7.0K | $575 | $23K |
| **Total Assets** | $77K | $95K | $144K | $142K | $128K | $17K | $17K | $25K |
| Accounts Payable | $6.1K | $6.0K | $6.0K | $6.0K | $6.1K | $9.2K | $3.9K | -- |
| Deferred Revenue (Current) | -- | $10K | $7.5K | $113K | $100K | -- | -- | $15K |
| **Total Current Liabilities** | $38K | -- | -- | -- | $108K | -- | -- | -- |
| **Total Non-Current Liabilities** | $22K | -- | -- | -- | $0 | -- | -- | -- |
| **Total Liabilities** | $60K | $64K | $77K | $122K | $108K | $14K | $8.9K | $18K |
| Common Stock | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K |
| Retained Earnings | -$348K | -$333K | -$298K | -$344K | -$345K | -$362K | -$356K | -$358K |
| **Total Stockholders' Equity** | -- | $32K | $67K | $21K | $19K | $2.7K | $8.2K | $7.1K |
| Total Equity | $16K | $32K | $67K | $21K | $19K | $2.7K | $8.2K | $7.1K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$2.9K | -$19K | -$66K | -$131K | -$109K |
| Change in Payables | -- | $6.1K | -- | -$1.0K | $565 |
| **Operating Cash Flow** | -$74K | $94K | -$91K | -$124K | -$4.3K |
| **Investing Cash Flow** | -- | -- | -- | -- | -$8.6K |
| Common Stock Issued | -- | -- | -- | -- | $364K |
| **Financing Cash Flow** | $22K | -- | -- | -- | $364K |
| **Net Change in Cash** | -$51K | $94K | -$91K | -$124K | $243K |

### Cash Flow Statement (Quarterly)

| Line Item | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$15K | -$38K | $71K | $1.2K | $17K | -$5.4K | $1.1K | -$31K |
| Change in Payables | -- | $0 | $0 | -$105 | -- | -- | -- | -- |
| **Operating Cash Flow** | -$14K | -$41K | -$37K | $18K | $115K | $6.4K | -$23K | -$4.9K |
| **Net Change in Cash** | -$14K | -$41K | -$15K | $18K | $115K | $6.4K | -$23K | -$4.9K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -0.4% | -18.5% | -187.7% | -873.9% | -253.2% |
| **Net Profit Margin** | -1.8% | -18.5% | -187.7% | -873.8% | -253.1% |
| Return on Equity (ROE) | -- | -97.6% | -172.1% | -126.2% | -46.3% |
| Return on Assets (ROA) | -3.8% | -14.8% | -171.0% | -110.5% | -43.5% |
| Quick Ratio | 1.85x | 1.12x | -- | -- | -- |
| **Revenue Growth (YoY)** | +61.4% | +191.5% | +133.3% | -65.1% | -- |
| Operating Cash Flow Growth (YoY) | -178.4% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -0.4% | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | 11.8% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | 161.8% | 124.5% | 65.5% | -97.6% | -117.2% | -227.7% | -1022.6% |
| Return on Assets (ROA) | 25.2% | 53.9% | 58.0% | 9.4% | -14.8% | -18.8% | -109.1% | -291.9% |
| Quick Ratio | 1.85x | -- | -- | -- | 1.12x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -57.3% | +614.9% | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -316.0% | -- | +6528.8% | -- | -48.6% | -- | -- | -- |
| **Net Income Growth (YoY)** | -192.5% | -- | +6504.4% | -- | -48.6% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -112.1% | -736.1% | -- | -- | +3761.2% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
